-
Je něco špatně v tomto záznamu ?
Determinants of therapeutic lag in multiple sclerosis
I. Roos, E. Leray, F. Frascoli, R. Casey, JWL. Brown, D. Horakova, EK. Havrdova, M. Debouverie, M. Trojano, F. Patti, G. Izquierdo, S. Eichau, G. Edan, A. Prat, M. Girard, P. Duquette, M. Onofrj, A. Lugaresi, P. Grammond, J. Ciron, A. Ruet, S....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33423618
DOI
10.1177/1352458520981300
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- postižení * MeSH
- posuzování pracovní neschopnosti MeSH
- progrese nemoci MeSH
- recidiva MeSH
- registrace MeSH
- relabující-remitující roztroušená skleróza * MeSH
- roztroušená skleróza * farmakoterapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: A delayed onset of treatment effect, termed therapeutic lag, may influence the assessment of treatment response in some patient subgroups. OBJECTIVES: The objective of this study is to explore the associations of patient and disease characteristics with therapeutic lag on relapses and disability accumulation. METHODS: Data from MSBase, a multinational multiple sclerosis (MS) registry, and OFSEP, the French MS registry, were used. Patients diagnosed with MS, minimum 1 year of exposure to MS treatment and 3 years of pre-treatment follow-up, were included in the analysis. Studied outcomes were incidence of relapses and disability accumulation. Therapeutic lag was calculated using an objective, validated method in subgroups stratified by patient and disease characteristics. Therapeutic lag under specific circumstances was then estimated in subgroups defined by combinations of clinical and demographic determinants. RESULTS: High baseline disability scores, annualised relapse rate (ARR) ⩾ 1 and male sex were associated with longer therapeutic lag on disability progression in sufficiently populated groups: females with expanded disability status scale (EDSS) < 6 and ARR < 1 had mean lag of 26.6 weeks (95% CI = 18.2-34.9), males with EDSS < 6 and ARR < 1 31.0 weeks (95% CI = 25.3-36.8), females with EDSS < 6 and ARR ⩾ 1 44.8 weeks (95% CI = 24.5-65.1), and females with EDSS ⩾ 6 and ARR < 1 54.3 weeks (95% CI = 47.2-61.5). CONCLUSIONS: Pre-treatment EDSS and ARR are the most important determinants of therapeutic lag.
Amiens University Hospital Department of Neurology place Victor Pauchet Amiens France
Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases Istanbul Turkey
Centre hospitalier universitaire Limoges Department of Neurology Hôpital Dupuytren Limoges France
Centro Hospitalar Universitário de São João and Universidade Fernando Pessoa Porto Portugal
CHU de Besançon Department of Neurology Besançon France
CHU de Dijon Department of Neurology EA4184 Dijon France
CHU de Montpellier MS Unit Montpellier France University of Montpellier Montpellier France
CHU de Nantes Service de Neurologie and CIC015 INSERM Nantes France CRTI Inserm U1064 Nantes France
CHU La Milétrie Hôpital Jean Bernard Department of Neurology Poitiers France
CHU Lille CRCSEP Lille Univ Lille U1172 Lille France
CHUM MS Center and Universite de Montreal Montreal QC Canada
CISSS Chaudière Appalache Lévis QC Canada
Cliniques universitaires Saint Luc UCLouvain Bruxelles Belgium
CSSS Saint Jérôme Saint Jerome QC Canada
Department of Basic Medical Sciences Neuroscience and Sense Organs University of Bari Bari Italy
Department of Clinical Neurosciences University of Cambridge Cambridge UK
Department of Neurology Centre hospitalier de Pontoise Hôpital René Dubos Pontoise France
Department of Neurology Centre Hospitalier Sud Francilien Corbeil Essonnes France
Department of Neurology Centre hospitalier universitaire Grenoble Alpes La Tronche Grenoble France
Department of Neurology Faculty of Medicine University of Debrecen Debrecen Hungary
Department of Neurology LR 18 SP03 CIC Neurosciences Razi Hospital La Manouba Tunisia
Department of Neurology Zuyderland Medical Center Sittard Geleen The Netherlands
Department of Neuroscience Azienda Ospedaliera Universitaria Modena Italy
Department of Neuroscience Imaging and Clinical Sciences University G d'Annunzio Chieti Italy
Division of Neurology Department of Medicine Amiri Hospital Sharq Kuwait
Dokuz Eylul University Konak Izmir Turkey
Fondation Adolphe de Rothschild de l'œil et du cerveau Department of Neurology Paris France
GF Ingrassia Department University of Catania Catania Italy Policlinico G Rodolico Catania Italy
Haydarpasa Numune Training and Research Hospital Istanbul Turkey
Hopital Andre Mignot Department of Neurology 177 Rue de Versailles Le Chesnay France
Hôpital Pierre Paul Riquet Department of Neurology CHU de Toulouse CRC SEP Toulouse France
Hospital Universitario Reina Sofia Cordoba Cordoba Spain
Hospital Universitario Virgen Macarena Sevilla Spain
Instituto de Investigación Sanitaria Biodonostia Hospital Universitario Donostia San Sebastian Spain
IRCCS Mondino Foundation Pavia Italy
KTU Medical Faculty Farabi Hospital Trabzon Turkey
Medical Faculty 19 Mayis University Samsun Turkey
Neuro Rive Sud Quebec QC Canada
Neurological Unit AORN San G Moscati Avellino Italy
Ospedali Riuniti di Salerno Salerno Italy
Rehabilitation and MS Centre Overpelt and Hasselt University Hasselt Belgium
UOC Neurologia Azienda Sanitaria Unica Regionale Marche AV3 Macerata Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003622
- 003
- CZ-PrNML
- 005
- 20220127150047.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/1352458520981300 $2 doi
- 035 __
- $a (PubMed)33423618
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Roos, Izanne $u CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia
- 245 10
- $a Determinants of therapeutic lag in multiple sclerosis / $c I. Roos, E. Leray, F. Frascoli, R. Casey, JWL. Brown, D. Horakova, EK. Havrdova, M. Debouverie, M. Trojano, F. Patti, G. Izquierdo, S. Eichau, G. Edan, A. Prat, M. Girard, P. Duquette, M. Onofrj, A. Lugaresi, P. Grammond, J. Ciron, A. Ruet, S. Ozakbas, J. De Seze, C. Louapre, H. Zephir, MJ. Sá, P. Sola, D. Ferraro, P. Labauge, G. Defer, R. Bergamaschi, C. Lebrun-Frenay, C. Boz, E. Cartechini, T. Moreau, D. Laplaud, J. Lechner-Scott, F. Grand'Maison, O. Gerlach, M. Terzi, F. Granella, R. Alroughani, G. Iuliano, V. Van Pesch, B. Van Wijmeersch, D. Spitaleri, A. Soysal, E. Berger, J. Prevost, E. Aguera-Morales, P. McCombe, T. Castillo Triviño, P. Clavelou, J. Pelletier, R. Turkoglu, B. Stankoff, O. Gout, E. Thouvenot, O. Heinzlef, Y. Sidhom, R. Gouider, T. Csepany, B. Bourre, A. Al Khedr, O. Casez, P. Cabre, A. Montcuquet, A. Wahab, JP. Camdessanche, A. Maurousset, I. Patry, K. Hankiewicz, C. Pottier, N. Maubeuge, C. Labeyrie, C. Nifle, A. Coles, CB. Malpas, S. Vukusic, H. Butzkueven, T. Kalincik
- 520 9_
- $a BACKGROUND: A delayed onset of treatment effect, termed therapeutic lag, may influence the assessment of treatment response in some patient subgroups. OBJECTIVES: The objective of this study is to explore the associations of patient and disease characteristics with therapeutic lag on relapses and disability accumulation. METHODS: Data from MSBase, a multinational multiple sclerosis (MS) registry, and OFSEP, the French MS registry, were used. Patients diagnosed with MS, minimum 1 year of exposure to MS treatment and 3 years of pre-treatment follow-up, were included in the analysis. Studied outcomes were incidence of relapses and disability accumulation. Therapeutic lag was calculated using an objective, validated method in subgroups stratified by patient and disease characteristics. Therapeutic lag under specific circumstances was then estimated in subgroups defined by combinations of clinical and demographic determinants. RESULTS: High baseline disability scores, annualised relapse rate (ARR) ⩾ 1 and male sex were associated with longer therapeutic lag on disability progression in sufficiently populated groups: females with expanded disability status scale (EDSS) < 6 and ARR < 1 had mean lag of 26.6 weeks (95% CI = 18.2-34.9), males with EDSS < 6 and ARR < 1 31.0 weeks (95% CI = 25.3-36.8), females with EDSS < 6 and ARR ⩾ 1 44.8 weeks (95% CI = 24.5-65.1), and females with EDSS ⩾ 6 and ARR < 1 54.3 weeks (95% CI = 47.2-61.5). CONCLUSIONS: Pre-treatment EDSS and ARR are the most important determinants of therapeutic lag.
- 650 _2
- $a posuzování pracovní neschopnosti $7 D004185
- 650 12
- $a postižení $7 D006233
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a roztroušená skleróza $x farmakoterapie $7 D009103
- 650 12
- $a relabující-remitující roztroušená skleróza $7 D020529
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a registrace $7 D012042
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Leray, Emmanuelle $u Rennes University, EHESP, REPERES - EA 7449, Rennes, France/Rennes University, CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)], Rennes, France
- 700 1_
- $a Frascoli, Federico $u Faculty of Science, Engineering and Technology, School of Science, Department of Mathematics, Swinburne University of Technology, Melbourne, VIC, Australia
- 700 1_
- $a Casey, Romain $u Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France/Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, France/Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, France/EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis, State-Approved Foundation, Bron, France
- 700 1_
- $a Brown, J William L $u CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- 700 1_
- $a Horakova, Dana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Havrdova, Eva Kubala $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Debouverie, Marc $u Department of Neurology, Nancy University Hospital, Nancy, France/Université de Lorraine, APEMAC, Nancy, France
- 700 1_
- $a Trojano, Maria $u Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy
- 700 1_
- $a Patti, Francesco $u GF Ingrassia Department, University of Catania, Catania, Italy/Policlinico G Rodolico, Catania, Italy
- 700 1_
- $a Izquierdo, Guillermo $u Hospital Universitario Virgen Macarena, Sevilla, Spain
- 700 1_
- $a Eichau, Sara $u Hospital Universitario Virgen Macarena, Sevilla, Spain
- 700 1_
- $a Edan, Gilles $u Centre hospitalier universitaire de Rennes, Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM, Rennes, France
- 700 1_
- $a Prat, Alexandre $u CHUM MS Center and Universite de Montreal, Montreal, QC, Canada
- 700 1_
- $a Girard, Marc $u CHUM MS Center and Universite de Montreal, Montreal, QC, Canada
- 700 1_
- $a Duquette, Pierre $u CHUM MS Center and Universite de Montreal, Montreal, QC, Canada
- 700 1_
- $a Onofrj, Marco $u Department of Neuroscience, Imaging, and Clinical Sciences, University G. d'Annunzio, Chieti, Italy
- 700 1_
- $a Lugaresi, Alessandra $u IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italia
- 700 1_
- $a Grammond, Pierre $u CISSS Chaudière-Appalache, Lévis, QC, Canada
- 700 1_
- $a Ciron, Jonathan $u Hôpital Pierre-Paul Riquet, Department of Neurology, CHU de Toulouse, CRC-SEP, Toulouse, France
- 700 1_
- $a Ruet, Aurélie $u University Bordeaux, Bordeaux, France/INSERM U1215, Neurocentre Magendie, Bordeaux, France/Department of Neurology, CHU de Bordeaux, CIC Bordeaux CIC1401, Bordeaux, France
- 700 1_
- $a Ozakbas, Serkan $u Dokuz Eylul University, Konak/Izmir, Turkey
- 700 1_
- $a De Seze, Jérôme $u CHU de Strasbourg, Department of Neurology and Clinical Investigation Center, CIC (centre d'investigation clinique) INSERM 1434, Strasbourg, France
- 700 1_
- $a Louapre, Céline $u Sorbonne Université, Institut du Cerveau, ICM, Assistance Publique Hôpitaux de Paris APHP, Département de neurologie, Hôpital de la Pitié Salpêtrière, Paris, France
- 700 1_
- $a Zephir, Hélène $u CHU Lille, CRCSEP Lille, Univ Lille, U1172, Lille, France
- 700 1_
- $a Sá, Maria José $u Centro Hospitalar Universitário de São João and Universidade Fernando Pessoa, Porto, Portugal
- 700 1_
- $a Sola, Patrizia $u Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy
- 700 1_
- $a Ferraro, Diana $u Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy
- 700 1_
- $a Labauge, Pierre $u CHU de Montpellier, MS Unit, Montpellier, France/University of Montpellier (MUSE), Montpellier, France
- 700 1_
- $a Defer, Gilles $u CHU de Caen, MS Expert Centre, Department of Neurology, avenue de la Côte-de-Nacre, Normandy University, Caen, France
- 700 1_
- $a Bergamaschi, Roberto $u IRCCS Mondino Foundation, Pavia, Italy
- 700 1_
- $a Lebrun-Frenay, Christine $u CRCSEP Nice, UR2CA, Université Nice Cote d'Azur, Centre hospitalier universitaire de Nice, Hopital Pasteur 2, Nice, France
- 700 1_
- $a Boz, Cavit $u KTU Medical Faculty Farabi Hospital, Trabzon, Turkey
- 700 1_
- $a Cartechini, Elisabetta $u UOC Neurologia, Azienda Sanitaria Unica Regionale Marche - AV3, Macerata, Italy
- 700 1_
- $a Moreau, Thibault $u CHU de Dijon, Department of Neurology, EA4184, Dijon, France
- 700 1_
- $a Laplaud, David $u CHU de Nantes, Service de Neurologie & CIC015 INSERM, Nantes, France/CRTI-Inserm U1064, Nantes, France
- 700 1_
- $a Lechner-Scott, Jeannette $u School of Medicine and Public Health, University Newcastle, Newcastle, NSW, Australia/Department of Neurology, John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia
- 700 1_
- $a Grand'Maison, Francois $u Neuro Rive-Sud, Quebec, QC, Canada
- 700 1_
- $a Gerlach, Oliver $u Department of Neurology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands
- 700 1_
- $a Terzi, Murat $u Medical Faculty, 19 Mayis University, Samsun, Turkey
- 700 1_
- $a Granella, Franco $u Department of Medicine and Surgery, University of Parma, Parma, Italy/Department of General Medicine, Parma University Hospital, Parma, Italy
- 700 1_
- $a Alroughani, Raed $u Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait
- 700 1_
- $a Iuliano, Gerardo $u Ospedali Riuniti di Salerno, Salerno, Italy
- 700 1_
- $a Van Pesch, Vincent $u Cliniques universitaires Saint-Luc, UCLouvain, Bruxelles, Belgium
- 700 1_
- $a Van Wijmeersch, Bart $u Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium
- 700 1_
- $a Spitaleri, Daniele LA $u Neurological Unit AORN San G. Moscati, Avellino, Italy
- 700 1_
- $a Soysal, Aysun $u Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey
- 700 1_
- $a Berger, Eric $u CHU de Besançon, Department of Neurology, Besançon, France
- 700 1_
- $a Prevost, Julie $u CSSS Saint-Jérôme, Saint-Jerome, QC, Canada
- 700 1_
- $a Aguera-Morales, Eduardo $u Hospital Universitario Reina Sofia Cordoba (IMIBIC), Cordoba, Spain
- 700 1_
- $a McCombe, Pamela $u University of Queensland, Brisbane, QLD, Australia/Royal Brisbane and Women's Hospital, Herston, QLD, Australia
- 700 1_
- $a Castillo Triviño, Tamara $u Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastian, Spain
- 700 1_
- $a Clavelou, Pierre $u CHU Clermont-Ferrand, Department of Neurology, Clermont-Ferrand, France/Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
- 700 1_
- $a Pelletier, Jean $u Aix Marseille Univ, APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, Marseille, France
- 700 1_
- $a Turkoglu, Recai $u Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
- 700 1_
- $a Stankoff, Bruno $u Sorbonne Universités, UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de la Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, Pars, France/Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France
- 700 1_
- $a Gout, Olivier $u Fondation Adolphe de Rothschild de l'œil et du cerveau, Department of Neurology, Paris, France
- 700 1_
- $a Thouvenot, Eric $u CHU de Nîmes, Department of Neurology, Nîmes, France/Institut de Génomique Fonctionnelle, UMR5203, INSERM 1191, Université de Montpellier, Montpellier, France
- 700 1_
- $a Heinzlef, Olivier $u Centre hospitalier intercommunal de Poissy Saint-Germain-en-Laye, Departement of Neurology, Poissy, France
- 700 1_
- $a Sidhom, Youssef $u Department of Neurology - LR 18 SP03 - CIC Neurosciences, Razi Hospital, La Manouba, Tunisia
- 700 1_
- $a Gouider, Riadh $u Department of Neurology - LR 18 SP03 - CIC Neurosciences, Razi Hospital, La Manouba, Tunisia/Faculty of Medicine, UTM, Tunis, Tunisia
- 700 1_
- $a Csepany, Tunde $u Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Bourre, Bertrand $u Centre hospitalier universitaire Rouen Normandie, Hôpital Charles-Nicolle, Departement of Neurology, Rouen, France
- 700 1_
- $a Al Khedr, Abdullatif $u Amiens University Hospital, Department of Neurology, place Victor Pauchet, Amiens, France
- 700 1_
- $a Casez, Olivier $u Department of Neurology, Centre hospitalier universitaire Grenoble-Alpes, La Tronche/Grenoble, France
- 700 1_
- $a Cabre, Philippe $u Centre hospitalier universitaire de Martinique, Department of Neurology, Hôpital Pierre Zobda-Quitman, Fort-de-France, France
- 700 1_
- $a Montcuquet, Alexis $u Centre hospitalier universitaire Limoges, Department of Neurology, Hôpital Dupuytren, Limoges, France
- 700 1_
- $a Wahab, Abir $u Assistance publique des hôpitaux de Paris, Department of Neurology, Hôpital Henri Mondor, Créteil, France
- 700 1_
- $a Camdessanche, Jean-Philippe $u Centre hospitalier universitaire de Saint-Étienne, Department of Neurology, Hôpital Nord, Saint-Étienne, France
- 700 1_
- $a Maurousset, Aude $u Centre hospitalier régional universitaire de Tours, Department of Neurology, Hôpital Bretonneau, CRCSEP, Tours, France
- 700 1_
- $a Patry, Ivania $u Department of Neurology, Centre Hospitalier Sud Francilien, Corbeil Essonnes, France
- 700 1_
- $a Hankiewicz, Karolina $u Department of Neurology, Hôpital Pierre Delafontaine, Centre Hospitalier de Saint-Denis, Saint-Denis, France
- 700 1_
- $a Pottier, Corinne $u Department of Neurology, Centre hospitalier de Pontoise, Hôpital René Dubos, Pontoise, France
- 700 1_
- $a Maubeuge, Nicolas $u CHU La Milétrie, Hôpital Jean Bernard, Department of Neurology, Poitiers, France
- 700 1_
- $a Labeyrie, Céline $u Assistance publique des hôpitaux de Paris, Hôpital Bicêtre, Department of Neurology, Le Kremlin Bicêtre, France
- 700 1_
- $a Nifle, Chantal $u Hopital Andre Mignot, Department of Neurology, 177 Rue de Versailles, Le Chesnay, France
- 700 1_
- $a Coles, Alasdair $u Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- 700 1_
- $a Malpas, Charles B $u CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia
- 700 1_
- $a Vukusic, Sandra $u Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon/Bron, France/Centre des Neurosciences de Lyon, Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, Lyon, France/Université Claude Bernard Lyon 1, Faculté de médecine Lyon Est, Lyon, France
- 700 1_
- $a Butzkueven, Helmut $u Central Clinical School, Monash University, Melbourne, Australia/Department of Neurology, The Alfred Hospital, Melbourne, VIC, Australia/Department of Neurology, Box Hill Hospital, Monash University, Melbourne, VIC, Australia
- 700 1_
- $a Kalincik, Tomas $u CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia
- 773 0_
- $w MED00006389 $t Multiple sclerosis (Houndmills, Basingstoke, England) $x 1477-0970 $g Roč. 27, č. 12 (2021), s. 1838-1851
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33423618 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150043 $b ABA008
- 999 __
- $a ok $b bmc $g 1751168 $s 1154771
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 27 $c 12 $d 1838-1851 $e 20210111 $i 1477-0970 $m Multiple sclerosis $n Mult Scler $x MED00006389
- LZP __
- $a Pubmed-20220113
